XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies

XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration

XtalPi Innovation Center and JingJiaHang BioPharma Announce Strategic Collaboration to Advance AI-Driven Radionuclide Drug Development

XtalPi Invests in MIT-Led Foundry Bio, Harnessing Generative AI to Transform the Trillion-Dollar Anti-Aging Market

XtalPi’s “New Paradigm in Synthetic Chemistry: AI and Robotics Symposium” Concludes Successfully

XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations 

XtalPi Announces Strategic Acquisition of Liverpool ChiroChem (LCC), Unlocking Unprecedented Power in Chemical Space Exploration

XtalPi Opens AI Drug Discovery Platform to Faculty and Students at China Pharmaceutical University

Using AI to Spread Love: XtalPi’s Children’s Poetry and Art Charity Initiative

XtalPi’s Intelligent Autonomous Lab Solution Platform Drives Multi-Industry Innovation

XtalPi and PaiLin Bio Join Forces to Empower Specialized Biopharma with AI Technology

XtalPi and Kula Bio Sign Multi-Million RMB R&D Agreement to Empower Agricultural Efficiency with AI-Driven Microbial Fertilizers